Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories established Pharmaceuticals — Annual Foreign Exchange Impact (%) (%)
Form 10-K MD&A ('Components of % Change' table)
Latest, FY2025
-0.8%
Period ended Dec 31, 2025
Change on a year earlier
+5.9 pts
-6.7% in FY2024
History
14 years
Since FY2012
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Established Pharmaceuticals — Annual Foreign Exchange Impact (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -0.8% | +5.9 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2024 | Dec 31, 2024 | -6.7% | +1.1 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2023 | Dec 31, 2023 | -7.8% | -1.3 pts | SEC Filing (0001628280-25-007110) ↗ |
| FY2022 | Dec 31, 2022 | -6.5% | -5.7 pts | SEC Filing (0001628280-24-005348) ↗ |
| FY2021 | Dec 31, 2021 | -0.8% | +5.2 pts | SEC Filing (0001628280-23-004026) ↗ |
| FY2020 | Dec 31, 2020 | -6.0% | -0.1 pts | SEC Filing (0001104659-22-025141) ↗ |
| FY2019 | Dec 31, 2019 | -5.9% | -2.1 pts | SEC Filing (0001104659-21-025751) ↗ |
| FY2018 | Dec 31, 2018 | -3.8% | -5.4 pts | SEC Filing (0001104659-20-023904) ↗ |
| FY2017 | Dec 31, 2017 | 1.6% | +8.4 pts | SEC Filing (0001047469-19-000624) ↗ |
| FY2016 | Dec 31, 2016 | -6.8% | +8.0 pts | SEC Filing (0001047469-18-000856) ↗ |
| FY2015 | Dec 31, 2015 | -14.8% | -8.9 pts | SEC Filing (0001047469-17-000744) ↗ |
| FY2014 | Dec 31, 2014 | -5.9% | -1.7 pts | SEC Filing (0001047469-16-010246) ↗ |
| FY2013 | Dec 31, 2013 | -4.2% | +2.3 pts | SEC Filing (0001047469-15-001377) ↗ |
| FY2012 | Dec 31, 2012 | -6.5% | – | SEC Filing (0001047469-14-001176) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Established Pharmaceuticals — Annual Foreign Exchange Impact (%) (%), annual FY2012–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/epd-fx-comp-yoy
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.